Back

Soluble LOX-1 (lectin-type oxidized LDL receptor 1) is associated with inflammation and mortality in aortic valve stenosis

31 August 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (3) - Biomarkers, biomechanics, and innovations in valve and vascular disorders Valvular Heart Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Muntadher Al Zaidi

University hospital Bonn, Bonn (Germany)

8 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor K. Sughimoto (Chiba, JP)
Abstract Video
Presentation thumbnail
Doctor Y. Morimoto (Suita, JP)
Abstract Video
Presentation thumbnail
Ms K. Lee (Singapore, SG)
Abstract
Presentation thumbnail
Doctor S. Zheng (Bern, CH)
Abstract

Access the full session

Session thumbnail
New perspectives in cardiology (3) - Biomarkers, biomechanics, and innovations in valve and vascular disorders

The Event

Event poster

ESC Congress 2025

31 August 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Valvular proteomic and micro-CT analysis in severe aortic stenosis patients with normal and elevated lipoprotein(a) levels
thumbnail
Congress Presentation
Whole-blood transcriptome unveils altered immune response in acute myocardial infarction patients with aortic valve sclerosis
thumbnail
Congress Presentation
NMR metabolomics reveals distinct metabolic profiles between aortic valve stenosis and sclerosis: The NOvel BIomarkers of Aortic valve stenosis Study (NOBIAS)

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources